Abstracts tagged "Hepatitis C and rheumatoid arthritis (RA)"

Abstract Number: 2387 • 2017 ACR/ARHP Annual Meeting
Prevalence of Hepatitis C Virus Infection in Egyptian Patients with Rheumatoid Arthritis
Dahlia Abdel Mohsen¹, Sherin H. Hamza¹, Nashwa Aly Morshedy¹, F. DeWolfe Miller² and Mahmoud S. Elzalabany^3,4, ¹Internal Medicine and Rheumatology Department, Faculty of Medicine, Ain Shams University, Cairo, Egypt, ²Department of Tropical Medicine, Medical Microbiology and Pharmacology, John A. Burns School of Medicine, University of Hawaii, Honolulu, HI, ³Internal Medicine Department, Ahmed Maher Teaching Hospital, Cairo, Egypt, ⁴Tahya Misr HCV Treatment Center, Luxor, Egypt
Background/Purpose: HCV is a major public health problem affecting approximately 2-3% of the world’s population with about 130-150 million people chronically infected worldwide. Egypt has…
Abstract Number: 1603 • 2015 ACR/ARHP Annual Meeting
Safety of Biologic and Non-Biologic Disease-Modifying Antirheumatic Drug (DMARD) Therapy in Veterans with Rheumatoid Arthritis and Chronic Hepatitis C Infection
Jeffrey R. Curtis^1,2, Mary Jane Burton³, Shou Yang¹, Lang Chen¹, Ted R. Mikuls⁴, Jasvinder A. Singh², Kevin L. Winthrop⁵ and John Baddley^2,6, ¹University of Alabama at Birmingham, Birmingham, AL, ²Birmingham VAMC, Birmingham, AL, ³Jackson VAMC, Jackson, MS, ⁴University of Nebraska Medical Center, Omaha, NE, ⁵Oregon Health and Science University, Portland, OR, ⁶Medicine, University of Alabama at Birmingham, Birmingham, AL
Background/Purpose: Among patients with rheumatoid arthritis and hepatitis C virus (HCV) infection, the impact of biologic and nonbiologic DMARD therapy on hepatotoxicity has received limited study.…
Abstract Number: 1425 • 2014 ACR/ARHP Annual Meeting
Screening Behavior and Prevalence of Hepatitis C Virus in Mexico
Cassandra Skinner-Taylor¹, Alejandro Erhard-Ramírez¹, David Vega-Morales², Jorge Esquivel-Valerio¹, Diana Flores-Alvarado², Daniel Treviño-Montes¹ and Ernesto Torres-López³, ¹Departamento de Medicina Interna del Hospital Universitario “Dr. José Eleuterio González”, Universidad Autónoma de Nuevo León, Servicio de Reumatología, Departamento de Medicina Interna del Hospital Universitario “Dr. José Eleuterio González”, Universidad Autónoma de Nuevo León, Monterrey, Mexico, ²Rheumatology, Hospital Universitario UANL, Monterrey, Mexico, ³Inmunología del Hospital Universitario “Dr. José Eleuterio González”, Universidad Autónoma de Nuevo León, Servicio de Inmunología del Hospital Universitario “Dr. José Eleuterio González”, Universidad Autónoma de Nuevo León, Monterrey, Mexico
Background/Purpose In some countries, the prevalence of Hepatitis C virus infection is high and sometimes the appropriate tests to detect it are not performed in…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].